The cost of Lomaira, a fast-acting insulin, varies depending on insurance coverage, pharmacy, and location. Without insurance, a prescription for Lomaira can range from approximately \$300 to over \$450 for a 10-pen supply [1].
What factors influence Lomaira's price?
Several factors can affect the out-of-pocket cost of Lomaira. These include:
* Insurance Coverage: Prescription drug plans often have tiered formularies, meaning the copay for a medication like Lomaira can differ significantly based on whether it is preferred, non-preferred, or not covered by the plan [2].
* Pharmacy Pricing: Different pharmacies may set different prices for the same medication. Comparing prices at various pharmacies can lead to cost savings [1].
* Dosage and Quantity: The total cost will depend on the prescribed dosage and the number of pens or vials dispensed [1].
* Savings Programs: Pharmaceutical manufacturers sometimes offer patient assistance programs or discount cards that can reduce the cost for eligible individuals [2].
Can I get financial assistance for Lomaira?
Yes, financial assistance may be available for Lomaira. Manufacturers of prescription medications, including insulin products, often provide savings cards or patient assistance programs. These programs can help eligible patients with commercial insurance or those who are uninsured to lower their out-of-pocket expenses [2]. Checking the manufacturer's official website or consulting with a pharmacist are good first steps to identify available savings options.
How does Lomaira's cost compare to other insulins?
Lomaira's pricing is generally in line with other rapid-acting insulin analogs. However, the overall cost of managing diabetes with insulin is influenced by many factors beyond the list price of a single product, including the total daily dose required, the duration of treatment, and the patient's insurance benefits [1][2].
When did Lomaira become available?
Lomaira was approved by the U.S. Food and Drug Administration (FDA) in September 2017 [3].
What is Lomaira used for?
Lomaira is a rapid-acting human insulin indicated for improving glycemic control in adults and children aged 6 years and older with diabetes mellitus [3]. It is intended to be used before mealtime to help manage blood glucose levels [3].
What are the potential side effects of Lomaira?
Common side effects of Lomaira include hypoglycemia (low blood sugar), allergic reactions, injection site reactions, and changes in vision [3]. Hypoglycemia is the most common and serious adverse effect of all insulin therapies [3].
How is Lomaira administered?
Lomaira is administered by subcutaneous injection [3]. It can be injected into the abdomen, thigh, or upper arm [3].
What is the difference between Lomaira and other insulins?
Lomaira is a rapid-acting insulin, meaning it starts to work quickly after injection, typically within 15 minutes, has a peak action within 1 to 2 hours, and lasts for 3 to 5 hours [3]. This differs from other types of insulin, such as short-acting, intermediate-acting, and long-acting insulins, which have different onset, peak, and duration of action profiles [3]. Lomaira is specifically designed for mealtime use [3].
Are there any drug interactions with Lomaira?
Lomaira can interact with various medications, including other diabetes medications, corticosteroids, diuretics, and certain antidepressants [3]. It is crucial to inform a healthcare provider about all medications, including over-the-counter drugs and herbal supplements, being taken to avoid potential interactions [3].
How should Lomaira be stored?
Unused Lomaira pens should be refrigerated at 36°F to 46°F (2°C to 8°C) [3]. Once a pen is in use or being carried, it can be kept at room temperature, not exceeding 86°F (30°C), for up to 28 days [3]. It should not be frozen and should be protected from heat and light [3].
What does the patent status of Lomaira look like?
Information on the patent status of Lomaira, including expiry dates and any related litigation, is available through resources like DrugPatentWatch.com [4]. Understanding patent landscapes is crucial for predicting when generic or biosimilar versions of a drug might become available, potentially impacting pricing and market competition [4].
Sources:
[1] https://www.goodrx.com/lomaira
[2] https://www.singlecare.com/drugs/lomaira
[3] https://www.lomaira.com/
[4] https://drugpatentwatch.com/